drugset / Trial / NCT03347331

[18F]-F13640 as a New Brain Radiopharmaceutical

NCT03347331 ↗

Phase 0 Completed 20 enrolled Hospices Civils de Lyon
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This clinical assay is designed to validate that \[18F\]F13640 as a radiotracer of 5-HT1A functional receptors. A first group of healthy subjects underwent a PET scan with arterial blood sampling to determine the kinetic model of the tracer. A second group of healthy subjects underwent a classical test-retest study (i.e two distant PET scans) to determine the reproducibility of measures.

Timeline

Start
2018-04-23
Primary completion
2021-04-23
Completion
2021-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]F13640 Diagnostic / imaging agent 1 mbq/kg Other
Subject [18F]F13640 Diagnostic / imaging agent 150 mbq Other